Vivus Widens Losses More Than Expected

Vivus Inc. (Nasdaq: VVUS) widened fourth quarter losses more than expected to 56 cents per share compared with 13 cents per share in the year ago period on disappointing sales of its recently approved obesity treatment Qsymia.


Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here